{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:05:44Z","timestamp":1761843944335},"reference-count":77,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.jacl.2007.02.003","type":"journal-article","created":{"date-parts":[[2009,9,24]],"date-time":"2009-09-24T08:06:59Z","timestamp":1253779619000},"page":"41-56","source":"Crossref","is-referenced-by-count":20,"title":["Severe acquired (secondary) high-density lipoprotein deficiency"],"prefix":"10.1016","volume":"1","author":[{"given":"Ronald B.","family":"Goldberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando J.","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2007.02.003_bib1","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1172\/JCI30163","article-title":"Molecular regulation of HDL metabolism and function: implications for novel therapies","volume":"12","author":"Rader","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2007.02.003_bib2","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2007.02.003_bib3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.atherosclerosis.2005.10.033","article-title":"Differential diagnosis of familial high density lipoprotein deficiency syndromes","volume":"186","author":"von Eckardstein","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2007.02.003_bib4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2007.02.003_bib5","first-page":"1","article-title":"Abdominal adipose tissue and serum HDL-cholesterol: association independent from obesity and serum triglyceride concentration","volume":"12","author":"Despres","year":"1988","journal-title":"Int J Obes"},{"key":"10.1016\/j.jacl.2007.02.003_bib6","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0950-351X(05)80245-9","article-title":"Insulin resistance and risk factors for coronary heart disease","volume":"7","author":"Laws","year":"1993","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2007.02.003_bib7","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/dmr.5610030303","article-title":"HDL metabolism in diabetes","volume":"3","author":"Chen","year":"1987","journal-title":"Diabetes Metab Rev"},{"key":"10.1016\/j.jacl.2007.02.003_bib8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.metabol.2005.07.012","article-title":"HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment","volume":"55","author":"Hansen","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.jacl.2007.02.003_bib9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0140-6736(78)91863-9","article-title":"Plasma-triglycerides in regulation of H.D.L.-cholesterol levels","volume":"2","author":"Schaefer","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2007.02.003_bib10","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/01.ATV.14.5.707","article-title":"Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size","volume":"14","author":"Brinton","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.jacl.2007.02.003_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00041433-200406000-00006","article-title":"High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease","volume":"15","author":"Rohrer","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2007.02.003_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000420010","article-title":"Effects of retinoids on lipoprotein metabolism","volume":"20","author":"Vahlquist","year":"1991","journal-title":"Curr Probl Dermatol"},{"issue":"3 suppl","key":"10.1016\/j.jacl.2007.02.003_bib13","doi-asserted-by":"crossref","first-page":"143S","DOI":"10.1016\/S0041-1345(03)00233-1","article-title":"Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients","volume":"35","author":"Morrisett","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jacl.2007.02.003_bib14","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(98)03391-1","article-title":"Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance","volume":"351","author":"Carr","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2007.02.003_bib15","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0026-0495(99)90056-2","article-title":"Influence of various modes of androgen substitution on serum lipids and lipoproteins in hypogonadal men","volume":"48","author":"Jockenhovel","year":"1999","journal-title":"Metabolism"},{"issue":"1A","key":"10.1016\/j.jacl.2007.02.003_bib16","doi-asserted-by":"crossref","first-page":"104S","DOI":"10.1016\/S0002-9343(99)80067-9","article-title":"The androgenicity of progestins","volume":"16","author":"Darney","year":"1995","journal-title":"Am J Med"},{"issue":"suppl 6","key":"10.1016\/j.jacl.2007.02.003_bib17","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1097\/00005344-199312050-00016","article-title":"Serum lipoproteins during treatment with antihypertensive drugs","volume":"22","author":"Weidmann","year":"1993","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacl.2007.02.003_bib18","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1161\/01.ATV.0000148706.15947.8a","article-title":"Probucol inhibits ABCA1-mediated cellular lipid efflux","volume":"24","author":"Favari","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2007.02.003_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/er.2005-0013","article-title":"The effect of select nutrients on serum high-density lipoprotein cholesterol and apolipoprotein A-I levels","volume":"27","author":"Mooradian","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jacl.2007.02.003_bib20","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1365-2362.1993.tb00724.x","article-title":"Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution","volume":"23","author":"Freeman","year":"1993","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jacl.2007.02.003_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ccc.2005.08.008","article-title":"Dyslipidemia in the critically ill","volume":"22","author":"Marik","year":"2006","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.jacl.2007.02.003_bib22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0022-2275(20)38119-0","article-title":"Plasma lipoprotein composition in alcoholic hepatitis: accumulation of apolipoprotein E-rich high density lipoprotein and preferential reappearance of \u201clight\u201d-HDL during partial recovery","volume":"23","author":"Weidman","year":"1982","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2007.02.003_bib23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0272-6386(12)80728-1","article-title":"Lipoprotein metabolism in normal and uremic patients","volume":"21","author":"Goldberg","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacl.2007.02.003_bib24","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/01.ATV.16.12.1430","article-title":"Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol","volume":"16","author":"Foger","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2007.02.003_bib25","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/S0140-6736(79)92007-5","article-title":"Plasma-triglycerides do not regulate high-density lipoprotein concentrations","volume":"1","author":"Herbert","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2007.02.003_bib26","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/01.CIR.90.3.1177","article-title":"Conjoint high triglycerides and low HDL cholesterol across generations","volume":"90","author":"Sprecher","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2007.02.003_bib27","doi-asserted-by":"crossref","unstructured":"Wendel M, Paul R, Heller AR. Lipoproteins in inflammation and sepsis. II. Clinical aspects. Intensive Care Med. 2006;Nov 9 [Epub ahead of print].","DOI":"10.1007\/s00134-006-0433-x"},{"key":"10.1016\/j.jacl.2007.02.003_bib28","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/01.CCM.0000059724.08290.51","article-title":"Lipoprotein metabolism in patients with severe sepsis","volume":"31","author":"van Leeuwen","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jacl.2007.02.003_bib29","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/00005373-198011000-00012","article-title":"Lipoprotein changes after burn injury in man","volume":"20","author":"Coombes","year":"1980","journal-title":"J Trauma"},{"key":"10.1016\/j.jacl.2007.02.003_bib30","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/ajcn\/45.2.414","article-title":"Changes of plasma levels of apolipoproteins A-I, A-II, and B and their isoforms in patients with intestinal failure receiving long-term parenteral nutrition","volume":"45","author":"Badimon","year":"1987","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacl.2007.02.003_bib31","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/0016-5085(83)90138-5","article-title":"Changes in plasma apolipoproteins A-I, A-II, and B, and lipoprotein cholesterol after jejunoileal bypass","volume":"84","author":"Goldberg","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacl.2007.02.003_bib32","first-page":"328","article-title":"Oxandrolone and plasma triglyceride reduction: effect on triglyceride-rich and high density lipoproteins","volume":"9","author":"Hara","year":"1981","journal-title":"Artery"},{"key":"10.1016\/j.jacl.2007.02.003_bib33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0026-0495(83)90052-5","article-title":"Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy","volume":"32","author":"Haffner","year":"1983","journal-title":"Metabolism"},{"key":"10.1016\/j.jacl.2007.02.003_bib34","doi-asserted-by":"crossref","first-page":"E1214","DOI":"10.1152\/ajpendo.00189.2002","article-title":"Metabolic effects of nandrolone decanoate and resistance training in men with HIV","volume":"283","author":"Sattler","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jacl.2007.02.003_bib35","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1210\/jc.86.11.5108","article-title":"Anabolic-androgenic steroid therapy in the treatment of chronic diseases","volume":"86","author":"Basaria","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2007.02.003_bib36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bjsm.2003.000199","article-title":"Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a)","volume":"38","author":"Hartgens","year":"2004","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.jacl.2007.02.003_bib37","first-page":"125","article-title":"Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia","volume":"5","author":"Tamai","year":"1979","journal-title":"Artery"},{"key":"10.1016\/j.jacl.2007.02.003_bib38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0021-9150(97)06108-X","article-title":"Abnormalities of serum apo A1 containing lipoprotein particles in patients with primary biliary cirrhosis","volume":"131","author":"O\u2019Kane","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2007.02.003_bib39","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI0214505","article-title":"Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element","volume":"109","author":"Claudel","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2007.02.003_bib40","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1590\/S0100-879X1997001100004","article-title":"Apolipoprotein and lipid abnormalities in chronic liver failure","volume":"30","author":"Sposito","year":"1997","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.jacl.2007.02.003_bib41","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/hep.1840030311","article-title":"High-density lipoprotein cholesterol and liver disease","volume":"3","author":"Kanel","year":"1983","journal-title":"Hepatology"},{"key":"10.1016\/j.jacl.2007.02.003_bib42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/00365521.1984.12005688","article-title":"Plasma alpha-lipoprotein pattern and LCAT activity in acute viral hepatitis in children","volume":"19","author":"Avgerinos","year":"1984","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jacl.2007.02.003_bib43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.1840060109","article-title":"High density lipoprotein subpopulations in chronic liver disease","volume":"6","author":"Chang","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.jacl.2007.02.003_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1524-475X.2002.10602.x","article-title":"Changes in serum levels of apolipoprotein A-1 as an indicator of protein metabolism after hepatectomy","volume":"10","author":"Katsuramaki","year":"2002","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.jacl.2007.02.003_bib45","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1210\/jc.82.5.1572","article-title":"Acute dyslipoproteinemia induced by interleukin-2: lecithin:cholesteryl acyltransferase, lipoprotein lipase, and hepatic lipase deficiencies","volume":"82","author":"Kwong","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2007.02.003_bib46","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.2337\/diabetes.54.8.2460","article-title":"Therapeutic roles of peroxisome proliferator-activated receptor agonists","volume":"54","author":"Staels","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jacl.2007.02.003_bib47","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1007\/s00125-005-1744-0","article-title":"Rosiglitazone up-regulates lipoprotein lipase, hormone-sensitive lipase and uncoupling protein-1, and down-regulates insulin-induced fatty acid synthase gene expression in brown adipocytes of Wistar rats","volume":"48","author":"Teruel","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacl.2007.02.003_bib48","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.2337\/diacare.28.9.2181","article-title":"Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo","volume":"28","author":"Schneider","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2007.02.003_bib49","doi-asserted-by":"crossref","first-page":"W80","DOI":"10.7326\/0003-4819-139-9-200311040-00022-w4","article-title":"Paradoxical lowering of high-density lipoprotein cholesterol level in 2 patients receiving fenofibrate and a thiazolidinedione","volume":"139","author":"Ebcioglu","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2007.02.003_bib50","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.2337\/diacare.27.11.2577","article-title":"Severe hypo-alpha-lipoproteinemia during treatment with rosiglitazone","volume":"27","author":"Sarker","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2007.02.003_bib51","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1345\/aph.1H020","article-title":"Paradoxically decreased HDL-cholesterol levels associated with rosiglitazone therapy","volume":"40","author":"Gutschi","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacl.2007.02.003_bib52","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5551\/jat.13.263","article-title":"Severe decrease in serum HDL-cholesterol during combination therapy of bezafibrate and pioglitazone","volume":"13","author":"Senba","year":"2006","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jacl.2007.02.003_bib53","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.diabres.2005.05.009","article-title":"The effect of dual PPAR alpha\/gamma stimulation with combination of rosiglitazone and fenofibrate on metabolic parameters in type 2 diabetic patients","volume":"71","author":"Seber","year":"2006","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jacl.2007.02.003_bib54","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2337\/db06-0481","article-title":"Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: prevention of fluid retention","volume":"56","author":"Boden","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.jacl.2007.02.003_bib55","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.2337\/diacare.27.9.2241","article-title":"Combination therapy with fenofibrate and rosiglitazone paradoxically lowers serum HDL cholesterol","volume":"27","author":"Normen","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacl.2007.02.003_bib56","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00125-003-1181-x","article-title":"Gemfibrozil considerably increases the plasma concentrations of rosiglitazone","volume":"46","author":"Niemi","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacl.2007.02.003_bib57","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00228-005-0042-6","article-title":"Effect of gemfibrozil on the pharmacokinetics of pioglitazone","volume":"61","author":"Deng","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jacl.2007.02.003_bib58","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0140-6736(94)91314-5","article-title":"Ciprofibrate and lipid profile","volume":"344","author":"Chandler","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2007.02.003_bib59","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0140-6736(94)92118-0","article-title":"Lipid profiles on fibric-acid derivatives","volume":"344","author":"Capps","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2007.02.003_bib60","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0140-6736(96)90436-5","article-title":"Abnormal lipid profiles on fibrate derivatives","volume":"347","author":"McLeod","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2007.02.003_bib61","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/000456329603300213","article-title":"Paradoxical high-density lipoprotein reduction induced by fenofibrate and ciprofibrate","volume":"33","author":"Collinson","year":"1996","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jacl.2007.02.003_bib62","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/000456329703400521","article-title":"Paradoxical high-density lipoprotein reduction induced by fibrate therapy","volume":"34","author":"Oleesky","year":"1997","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jacl.2007.02.003_bib63","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/000456329703400120","article-title":"Fibrates and HDL cholesterol","volume":"34","author":"Murphy","year":"1997","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jacl.2007.02.003_bib64","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/jcp.53.10.796","article-title":"A paradoxical severe decrease in serum HDL-cholesterol after treatment with a fibrate","volume":"53","author":"Crook","year":"2000","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jacl.2007.02.003_bib65","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1136\/pgmj.71.838.498","article-title":"Iatrogenic profound hypoalphalipoproteinaemia: an unrecognised cause of very low HDL cholesterol","volume":"71","author":"Murphy","year":"1995","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jacl.2007.02.003_bib66","doi-asserted-by":"crossref","first-page":"31012","DOI":"10.1016\/S0021-9258(18)47383-8","article-title":"Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element","volume":"269","author":"Vu-Dac","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2007.02.003_bib67","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1006\/bbrc.1994.1110","article-title":"Fenofibric acid modulates the human apolipoprotein A-IV gene expression in HepG2 cells","volume":"198","author":"Bovard-Houppermans","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jacl.2007.02.003_bib68","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/000456329903600420","article-title":"Metabolism of apolipoproteins AI and AII in a patient with paradoxical reduction in high-density lipoprotein due to ciprofibrate","volume":"36","author":"Beghin","year":"1999","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jacl.2007.02.003_bib69","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1161\/01.ATV.0000032153.19645.5C","article-title":"Acquired HDL deficiency associated with apolipoprotein A-I reactive monoclonal immunoglobulins","volume":"22","author":"Mendez","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2007.02.003_bib70","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/clinchem\/48.6.964","article-title":"Monoclonal paraprotein may interfere with the Roche direct HDL-C Plus assay","volume":"48","author":"Kadri","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2007.02.003_bib71","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5858\/2003-127-55-AHDTP","article-title":"Artifactual hyperbilirubinemia due to paraprotein interference","volume":"127","author":"Pantanowitz","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jacl.2007.02.003_bib72","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/pgmj.60.705.449","article-title":"Plasma cholesterol concentration and extra lipid band in monoclonal gammopathies","volume":"60","author":"Levy","year":"1984","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jacl.2007.02.003_bib73","first-page":"675","article-title":"Quantitative abnormalities of lipoprotein particles in multiple myeloma","volume":"25","author":"Hachem","year":"1987","journal-title":"J Clin Chem Clin Biochem"},{"key":"10.1016\/j.jacl.2007.02.003_bib74","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1373\/clinchem.2003.027813","article-title":"Artifactual undetectable HDL-cholesterol with the Beckman synchron LX and vitros 950 assays temporally associated with a paraprotein","volume":"50","author":"Baca","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2007.02.003_bib75","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1179\/acb.2004.039","article-title":"Protein precipitation as a possible important pitfall in the clinical chemistry analysis of blood samples containing monoclonal immunoglobulins: 2 case reports and a review of the literature","volume":"59","author":"Berth","year":"2004","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.jacl.2007.02.003_bib76","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.cccn.2005.02.008","article-title":"Falsely low LDL-cholesterol concentrations and artifactual undetectable HDL-cholesterol measured by direct methods in a patient with monoclonal paraprotein","volume":"358","author":"Tsai","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacl.2007.02.003_bib77","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1056\/NEJMcpc069031","article-title":"Case records of the Massachusetts General Hospital","volume":"355","author":"Murali","year":"2006","journal-title":"N Engl J Med"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287407000128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287407000128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T05:06:09Z","timestamp":1633928769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287407000128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S1933287407000128"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2007.02.003","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}